Viking Therapeutics VKTX Current ratio

Current ratio at other companies

Eli LillyLLY

1.4×+0.1×

PfizerPFE

1.2×0.0×

AmgenAMGN

1.4×+0.1×

Gyre Therapeutics, Inc.GYRE

4.3×-1.1×

Madrigal Pharmaceuticals, Inc.MDGL

3.2×-1.9×

VAN

Vivani MedicalVANI

3.2×+0.8×

FAQ

What is Viking Therapeutics's current ratio?

Viking Therapeutics (VKTX) reported current ratio of 5.7× in Q1 2026.

How has Viking Therapeutics's current ratio changed year-over-year?

Viking Therapeutics's current ratio decreased by 87.1% year-over-year, from 44.2× to 5.7×.

What is the long-term trend for Viking Therapeutics's current ratio?

Over 5 years (2020 to 2025), Viking Therapeutics's current ratio has grown at a -15.1% compound annual growth rate (CAGR), from 21.1× to 9.3×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.